Eli Lilly just shared some new information. That data suggests it has an advantage against Novo Nordisk in a key market.
Eli Lilly and Company announced earlier this week that its popular obesity drug, Zepbound (tirzepatide) outperformed rival ...
It didn’t take long for the shine to come off one of biotech’s recent IPO success stories, with BioAge Labs scrapping a phase ...
Eli Lilly is spending another $3 billion to bulk up manufacturing as the drugmaker seeks to stoke production of some blockbuster drugs and future products.
Monday looks likely to be a tough day for BioAge Labs, a US biopharma developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging.
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Eli Lilly, which fell to 35th place from 11th last year ... and sales of its diabetes drug Mounjaro and weight-loss injection ...
08 December 2024, 19:58 Ousted Syrian president Bashar Assad and his family are in Moscow and have been granted political asylum, Russian news agencies said. 08 December 2024, 17:32 Israeli reports: ...
Stock futures edged lower Monday morning as investors eye this week’s key inflation report. The Consumer Price Index (CPI) ...
The foreign ministry of Russia, a longtime ally, did not provide details on where President Bashar al-Assad had gone. Rebels stormed the Syrian capital on Sunday without encountering any ...
Jupiter at Opposition This Weekend: Here's the Best Time to See It ...
Skipping school to watch the Super Bowl might pay off for Jordan Petaia, who has quit rugby to scratch his NFL itch. New Zealand's latest prodigy 19-year-old Oli Mathis showed off an unconventional ...